Sernova CEO Philip Toleikis

“This is Becoming a Reality” – Sernova’s Cell Therapy Approach to a Functional T1D Cure

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/23395628/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_486_Final_Sernova_Toleikis.mp3″ libsyn_item_id=”23395628″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]Big news from Sernova, one of the companies hoping that implantable stem cells will be a functional cure for diabetes. They recently announced that the first person in their trials with type 1 is completely off injected or infused insulin…